We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Getein Biotech, Inc.

Getein Biotech, Inc. is a fully integrated in vitro diagnostic company that develops, manufactures and distributes an... read more Featured Products: More products

Download Mobile App





Getein Biotech Exhibits Advanced POCT Analyzers

By LabMedica International staff writers
Posted on 13 Nov 2023
Print article
Image: The Metis 6000 Modular System is being highlighted at MEDICA 2023 (Photo courtesy of Getein)
Image: The Metis 6000 Modular System is being highlighted at MEDICA 2023 (Photo courtesy of Getein)

Getein Biotech, Inc. (Nanjing, China) is exhibiting its range of advanced analyzers for point-of-care testing at MEDICA 2023.

At the MEDICA show, visitors to the Getein booth can experience its unique products and services first-hand that deliver efficient diagnostic and treatment solutions, helping healthcare professionals increase efficiency, reduce costs, and deliver a better patient experience. Getein is highlighting its Metis 6000 Modular System (Integrated Clinical Chemistry and Immunochemistry) that helps labs unlock efficiency and optimize space. The Metis 6000 Modular System comprises the MAGICL 6200 immunochemistry module with a throughput of up to 400 T/H, the CM-1000 clinical chemistry module with a throughput of up to 1000 T/H, and the SHC 200 pre-analytical module (optional) with a speed of 190 tubes/H.

Getein is also showcasing the Metis 600 Modular System (Integrated Immunofluorescence and Hematology) which provides a suitable solution for immunofluorescence and hematology testing in low-volume laboratories. The Metis 600 Modular System comprises the Getein 1200 immunofluorescence quantitative analyzer and the BHA-5100 automatic hematology analyzer. The combination of immunofluorescence and hematology methodologies allows for more comprehensive test items to be offered. Also on display at MEDICA 2023 is the BHA-5000 automatic 5-part differential hematology analyzer which uses laser-based flow cytometry to count white blood cells in blood samples. It also uses electrical impedance to count red blood cells and platelets, and colorimetry to measure the hemoglobin, and relevant parameters will be enumerated.

In addition, Getein is exhibiting the MAGICL 6000 chemiluminescence immunoassay analyzer designed for mid to high-workflow laboratories that require a one-step chemiluminescence solution. Alongside MAGICL 6000 was the Getein 1600 fully-automated immunofluorescence quantitative analyzer which combined with bar-coded, ready-to-use strip cassettes, delivers accurate testing results in minutes. The company is demonstrating the Getein 208 hand-held integrated system which is intended to detect and quantify specific chemical components in human blood serum, plasma, whole blood, capillary blood, and urine samples through dry chemistry and fluorescence immunoassay. Visitors to the company’s booth can learn about Getein’s POCT test menu which includes a wide range of reagent options, covering rapid testing for various diseases and health indicators.

Related Links:
Getein Biotech, Inc. 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: The new AI tool can help beat brain tumors (Photo courtesy of Crystal Light/Shutterstock)

New AI Tool Classifies Brain Tumors More Quickly and Accurately

Precision in diagnosing and categorizing tumors is essential for delivering effective treatment to patients. Currently, the gold standard for identifying various types of brain tumors involves DNA methylation-based... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.